About
Technology
Issues
FAQ
Links
Official Page
In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.